Some emerging principles underlying the physical properties, biological actions, and utility of vitrification solutions.
Vitrification solutions are aqueous cryoprotectant solutions which do not freeze when cooled at moderate rates to very low temperatures. Vitrification solutions have been used with great success for the cryopreservation of some biological systems but have been less successful or unsuccessful with other systems, and more fundamental knowledge about vitrification solutions is required. The purpose of the present survey is to show that a general understanding of the physical behavior and biological effects of vitrification solutions, as well as an understanding of the conditions under which vitrification solutions are required, is gradually emerging. Detailed nonequilibrium phase diagram information in combination with specific information on the tolerance of biological systems to ice and to cryoprotectant at subzero temperatures provides a quantitative theoretical basis for choosing between vitrification and freezing. The vitrification behavior of mixtures of cryoprotective agents during cooling is predictable from the behavior of the individual agents, and the behavior of individual agents is gradually becoming predictable from the details of their molecular structures. Progress is continuing concerning the elucidation of mechanisms and cellular sites of toxicity and mechanisms for the reduction of toxicity. Finally, important new information is rapidly emerging concerning the crystallization of previously vitrified cryoprotectant solutions during warming. It appears that vitrification tendency, toxicity, and devitrification all depend on subtle variations in the organization of water around dissolved substances.
D000818:Animals; D002477:Cells / Q000187:drug effects; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D003451:Cryoprotective Agents / Q000633:toxicity; D007668:Kidney / Q000187:drug effects; D009994:Osmolar Concentration; D011309:Preservation, Biological / Q000009:adverse effects; D012996:Solutions / Q000633:toxicity
D003451:Cryoprotective Agents; D012996:Solutions